Diametric Capital’s Eli Lilly LLY Stock Holding History

Diametric Capital’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.15M	Buy	+957	New	+$978K	0.12%	190
2024 Q4	–	Sell	-1,013	Closed	-$897K	–	397
2024 Q3	$897K	Sell	1,013 -652	-39%	-$586K	0.44%	56
2024 Q2	$1.51M	Buy	1,665 +470	+39%	+$376K	0.82%	22
2024 Q1	$930K	Buy	1,195 +362	+43%	+$258K	0.52%	49
2023 Q4	$486K	Sell	833 -494	-37%	-$288K	0.3%	106
2023 Q3	$713K	Buy	1,327 +139	+12%	+$71.6K	0.3%	103
2023 Q2	$557K	Buy	+1,188	New	+$498K	0.25%	112
2022 Q4	–	Sell	-3,213	Closed	-$1.04M	–	345
2022 Q3	$1.04M	Buy	+3,213	New	+$1.02M	0.52%	60
2020 Q1	–	Sell	-18,813	Closed	-$2.47M	–	144
2019 Q4	$2.47M	Buy	+18,813	New	+$2.18M	1.81%	14
2018 Q1	–	Sell	-9,389	Closed	-$793K	–	106
2017 Q4	$793K	Buy	+9,389	New	+$799K	0.48%	75

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Diametric Capital's LLY Position: Q2 2026 in Review

Diametric Capital opened a new position in Eli Lilly (LLY) in Q2 2026: 957 shares worth $1.15M. The stake represents 0.12% of the portfolio and ranks #190 among its holdings. This is a return to the name: Diametric Capital previously reported a position in LLY as recently as Q3 2024.

Diametric Capital first reported a position in LLY in Q4 2017 and has held it in 10 quarters since. The position peaked at $2.47M in Q4 2019. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Diametric Capital held 957 shares of Eli Lilly worth $1.15M as of Q2 2026.
Eli Lilly was a new Diametric Capital position in Q2 2026.
Eli Lilly made up 0.12% of Diametric Capital's portfolio in Q2 2026, its #190 holding.
Diametric Capital first reported a position in Eli Lilly in Q4 2017 and has held it in 10 quarters since.
Diametric Capital's Eli Lilly position peaked at $2.47M in Q4 2019.
4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Diametric Capital's 13F filing for Q2 2026, filed 14 Aug 2026.